The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.

The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.

Revvity expects full-year earnings in the range of $4.90 to $5 per share, with revenue in the range of $2.8 billion to $2.85 billion. This story was generated by Automated Insights ...

Wednesday’s fatal crash of a civilian plane and military helicopter at Reagan National Airport may reflect rising stresses on ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

Thermo Fisher Scientific (TMO) stock gains as the company beats Q4 2024 expectations and sets 2025 earnings outlook in line ...

Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...

For the current quarter ending in March, Dynatrace expects its per-share earnings to range from 29 cents to 31 cents. The company said it expects revenue in the range of $432 million to $437 million ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Thermo Fisher Scientific Inc. (TMO) on Thursday reported fourth-quarter profit of $1.83 billion. On a per-share basis, the Waltham, Massachusetts-based ...

In a report released today, Christian Schwab from Craig-Hallum maintained a Buy rating on Evolv Technologies Holdings (EVLV – Research Report).

Lake Street analyst Eric Martinuzzi maintained a Hold rating on Evolv Technologies Holdings (EVLV – Research Report) today and set a price ...

Looking at the period from July 2021 until July 2024, the names on InvestmentNews' second annual fastest-growing fee-only RIA report saw a three-year growth rate of 210.3 percent on average, with an ...